Видео ютуба по тегу Medicines: Lenalidomide

The need to improve treatment options for patients with lenalidomide-refractory multiple myeloma
The need to improve treatment options for patients with lenalidomide-refractory multiple myeloma
The management of patients with lenalidomide-refractory multiple myeloma in the UK
The management of patients with lenalidomide-refractory multiple myeloma in the UK
Graham Jackson, MD: Lenalidomide Maintenance Is Effective in All Types of Myeloma Patients
Graham Jackson, MD: Lenalidomide Maintenance Is Effective in All Types of Myeloma Patients
FIRST trial: Continuous lenalidomide plus dexamethasone for newly diagnosed multiple myeloma
FIRST trial: Continuous lenalidomide plus dexamethasone for newly diagnosed multiple myeloma
All About Revlimid (lenalidomide) #myeloma
All About Revlimid (lenalidomide) #myeloma
What is lenalidomide and when is it used for MDS?
What is lenalidomide and when is it used for MDS?
Lenalidomide maintenance – an active approach to treating MM?
Lenalidomide maintenance – an active approach to treating MM?
OPTIMISMM: investigating an alternative therapy for lenalidomide-refractory patients
OPTIMISMM: investigating an alternative therapy for lenalidomide-refractory patients
Optimal use of lenalidomide as therapy for MDS
Optimal use of lenalidomide as therapy for MDS
Dr. Durie on Revlimid Plus Dexamethasone Versus Standard Treatment for Multiple Myeloma
Dr. Durie on Revlimid Plus Dexamethasone Versus Standard Treatment for Multiple Myeloma
Dr. Jackson on the Toxicity Profile of Lenalidomide Maintenance in Myeloma
Dr. Jackson on the Toxicity Profile of Lenalidomide Maintenance in Myeloma
Results Establishing Lenalidomide Plus Rituximab as Superior Treatment in Non-Hodgkin Lymphoma
Results Establishing Lenalidomide Plus Rituximab as Superior Treatment in Non-Hodgkin Lymphoma
Managing lenalidomide-refractory myeloma patients
Managing lenalidomide-refractory myeloma patients
Teclistamab in Combination with Sub-Q Daratumumab and Lenalidomide in Myeloma Pts: MajesTEC-2
Teclistamab in Combination with Sub-Q Daratumumab and Lenalidomide in Myeloma Pts: MajesTEC-2
Lenalidomide (Revlimid) for Multiple Myeloma, Mantle Cell Lymphoma and Myelodysplastic Syndromes
Lenalidomide (Revlimid) for Multiple Myeloma, Mantle Cell Lymphoma and Myelodysplastic Syndromes
The impact of lenalidomide on second primary malignancies: long-term data from the Myeloma XI Trial
The impact of lenalidomide on second primary malignancies: long-term data from the Myeloma XI Trial
Benefit of treating smouldering myeloma patients early with lenalidomide & dexamethasone
Benefit of treating smouldering myeloma patients early with lenalidomide & dexamethasone
Maintenance treatment in myeloma
Maintenance treatment in myeloma
Combining bortezomib and lenalidomide-based regimens for frontline MM
Combining bortezomib and lenalidomide-based regimens for frontline MM
Lenalidomide and Ixazomib: a successful amyloidosis treatment combination?
Lenalidomide and Ixazomib: a successful amyloidosis treatment combination?